U.S. pharma giant copyright scrapped two experimental weight loss drugs final year—a the moment-day by day pill, lotiglipron, resulting from elevated liver enzymes and also a 2 times-daily capsule, danuglipron, as a consequence of solid Uncomfortable side effects—but CEO Albert Bourl